ABVC vs HAL · rev $509.6K vs P/E 9.3, $19.05B cap
ABVC Biopharma Inc (ABVC) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported ABVC revenue for 2024-12-31 was $509.6K. Net income was -$5.3M. Revenue was up 234.3% from 2023-12-31 to 2024-12-31. ABVC currently screens at market cap $35.9M.
HAL does not have a complete income-statement cache yet.
ABVC currently screens at market cap $35.9M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the ABVC and HAL stock pages for the full models.
Not investment advice.